Anti-LRRC19 antibodies are used in the immunodetection of the protein leucine rich repeat containing 19. In humans, the canonical protein has a reported length of 370 amino acid residues and a mass of 42.3 kDa. Its subcellular localization is in the membrane. It is reported to be expressed in renal collecting duct epithelial cells. LRRC19 is reported to be a pathogen-recognition receptor, which mediates the activation of TRAF2- and TRAF6 NF-kappa-B signaling pathways and induces the expression of pro-inflammatory cytokines. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include leucine-rich repeat-containing protein 19. LRRC19 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. Western Blot is the most common application for the LRRC19 antibodies listed below. ELISA, Immunocytochemistry, Immunofluorescence, and Immunohistochemistry are also common applications.